Washington D.c. Veterans Affairs Medical Center
Clinical trials sponsored by Washington D.c. Veterans Affairs Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy aims to shield kidneys in african american veterans Results expected Jul 2027 (estimated)
-
Can a diabetes drug shield kidney cells in Non-Diabetic kidney disease?
Disease control Recruiting nowThis trial tests whether empagliflozin, a drug already used for diabetes, can protect kidney cells in African American veterans who have chronic kidney disease but do not have diabetes. Participants will take either empagliflozin or a placebo daily for four months. Researchers wi…
Phase 4 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer: enhertu trial launches
Disease control Recruiting nowThis phase 2 trial tests Enhertu, a targeted drug, in 60 men with HER2-positive prostate cancer that has spread and stopped responding to hormone therapy and newer drugs like abiraterone. Participants must have tried or refused chemotherapy. The study measures tumor shrinkage and…
Phase 2 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Sound waves aimed at the brain could quiet chronic pain
Symptom relief Recruiting nowThis study tests whether low-intensity focused ultrasound (LIFU) can temporarily change activity in a brain area called the insula, which is involved in chronic pain. Veterans with chronic back pain and widespread pain symptoms will receive either real or sham LIFU to see if it r…
Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC